13 Best Low Priced Pharma Stocks to Buy Now

Page 3 of 12

10. Biohaven Ltd. (NYSE:BHVN)

Share Price as of July 14: $14.19

Number of Hedge Fund Holders: 37

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders, announced a multi-program research collaboration with Biohaven. The partnership aims to identify, de-risk, and advance next-gen therapies for CNS disorders.

This collaboration centers on Bexorg’s novel whole-brain discovery platform. The unique technology was developed by Bexorg’s founders at Yale University and is capable of perfusing isolated, cadaver human and pig brains with custom-made artificial blood. This process restores metabolic and molecular activity for prolonged periods, which allows Bexorg to extract high-resolution transcriptomic, proteomic, and metabolic insights in disease-relevant states.

By using this information, Bexorg is building physiologically relevant datasets in human neurodegeneration, which are crucial for ML and AI-centered CNS drug discovery and development. The platform’s ability to collect longitudinal data provides an advantage over other preclinical models in neuroscience by enabling the validation of new targets and biomarkers and the understanding of pharmacokinetic and pharmacodynamic profiles.

Biohaven Ltd. (NYSE:BHVN) discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

Page 3 of 12